Correlation Engine 2.0
Clear Search sequence regions


  • adult (5)
  • ASRS (2)
  • diagnosis (2)
  • help (1)
  • humans (1)
  • immunoglobulin e (2)
  • iran (1)
  • patients (9)
  • seizures (11)
  • seizures focal (2)
  • Sizes of these terms reflect their relevance to your search.

    We investigated the rates of positive screening for attention deficit-hyperactivity disorder (ADHD) in adults with seizures [i.e., focal epilepsy vs. idiopathic generalized epilepsy (IGE) vs. functional seizures (FS)]. We hypothesized that the rates of positive screening for ADHD are different between these three groups of patients. This was a cross sectional study. Patients, 19 to 55 years of age, with a diagnosis of IGE, focal epilepsy or FS were investigated at the outpatient epilepsy clinic at Shiraz University of Medical Sciences, Shiraz, Iran, from September 2022 until January 2023 and during their follow-up visits. We used the validated Persian version of Adult ADHD Self-Report Scale (ASRS v1.1)15 to investigate and screen for ADHD in these patients. Forty patients with focal epilepsy, 40 with IGE, and 40 with FS were included. Attention deficit-hyperactivity disorder (ADHD) screening was positive in 35% of patients with FS, in 30% of those with focal epilepsy (compared with FS, p = 0.633), and in 10% of patients with IGE (compared with FS, p = 0.007). Adult patients with functional seizures and those with focal epilepsy are at a high risk of self-reporting experiences that could be characteristic of ADHD. Screening tools [e.g., Adult ADHD Self-Report Scale (ASRS v1.1)] are useful to help clinicians address seizure comorbidities such as ADHD. However, a clinical diagnosis of ADHD should be ascertained in a patient with positive screening. Copyright © 2023 Elsevier Ltd. All rights reserved.

    Citation

    Ali A Asadi-Pooya, Mohsen Farazdaghi, Hanieh Asadi-Pooya, Khatereh Fazelian. Attention deficit hyperactivity disorder in patients with seizures: Functional seizures vs. epilepsy. Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia. 2023 Sep;115:20-23

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 37459827

    View Full Text